Nurix Therapeutics Inc【NRIX】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25 1Q26
売上高 - 6,689 5,011 7,091 10,252 7,396 9,621 11,432 10,791 6,783 12,685 30,676 18,467 15,159 16,585 12,092 12,588 13,284 18,453 44,056 7,894 13,577 6,252
売上成長率(%) - - - - - 11.3 264.3 -37.3 2.2 -66.1
研究開発費 18,939 20,445 23,003 25,994 30,906 36,531 43,137 47,493 47,761 46,106 45,816 45,763 47,856 49,713 50,005 48,922 55,481 67,224 69,663 78,096 86,120 83,024 84,137
営業費用 23,277 26,697 29,533 33,505 39,249 45,349 52,365 57,147 57,509 55,473 55,637 57,441 58,479 60,493 61,804 60,632 67,199 77,941 81,317 92,378 99,279 96,672 98,747
営業利益 -19,192 -20,008 -24,522 -26,414 -28,997 -37,953 -42,744 -45,715 -46,718 -48,690 -42,952 -26,765 -40,012 -45,334 -45,219 -48,540 -54,611 -64,657 -62,864 -48,322 -91,385 -83,095 -92,495
営業利益率 (%) - -340.7 -109.7 -1157.7 -612.0 -1479.4
経常(税引前)利益 -18,517 -19,873 -24,204 -26,243 -28,958 -37,658 -42,533 -45,401 -45,709 -46,717 - - - - -41,428 -44,456 -48,874 -58,541 -56,351 -42,704 -86,421 -78,221 -
経常(税引前)利益率(%) - -297.1 -483.0 -370.1 -282.5 -509.2 -442.1 -397.1 -423.6 -688.7 - - - - -249.8 -367.6 -388.3 -440.7 -305.4 -96.9 -1094.8 -576.1 -
法人税等合計 - 41 71 139 -100 31 - - - - - - - - 90 90 82 8 - 760 0 0 -
実効税率(%) - - - - - - - - - - -1.8 0.0 0.0 -
純利益 -18,517 -19,914 -24,275 -26,382 -28,835 -37,702 -42,533 -45,401 -45,709 -46,717 -40,733 -24,277 -36,982 -41,956 -41,518 -44,546 -48,956 -58,549 -56,351 -43,464 -86,421 -78,221 -87,174
純利益率(%) - -305.4 -98.7 -1094.8 -576.1 -1394.3
一株あたり利益 - - - -0.6 - - - -1.01 -0.9 -0.86 -0.75 -0.45 -0.68 -0.77 -0.76 -0.71 -0.67 -0.75 -0.67 -0.52 -1.03 -0.83 -0.79
希薄化後一株あたり利益 - - - -0.6 - - - -1.01 -0.9 -0.86 -0.75 -0.45 -0.68 -0.77 -0.76 -0.71 -0.67 -0.75 -0.67 -0.52 -1.03 -0.83 -0.79
一株あたり配当金 - - 0 0 0 - 0 0 0 - - - - - - - - - - - - - -